Fathom Therapeutics secures $55 million in Series A financing, led by Sutter Hill Ventures, to advance its AI-driven drug discovery platform.
Amount Raised
$55 Million
Round Type
Series A
Investors
Description
Fathom Therapeutics has raised $55 million in a Series A financing round led by Sutter Hill Ventures. The investment will help advance their innovative drug discovery platform utilizing quantum chemistry and AI. Kos Biotechnology Partners participated as an investor alongside other leading firms. This funding positions Fathom to potentially revolutionize the approach to drug discovery.
Who to call at Fathom Therapeutics, and when
A new round usually means Fathom Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Fathom Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Fathom Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Fathom Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Fathom Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansFathom Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.